Lilly Endowment to sell 220,000 LLY shares ($197,236,600)

Lilly Endowment Inc. filed a Form 144 notice to sell up to 220,000 shares of Eli Lilly and Company (LLY) common stock, reflecting an aggregate market value of $197,236,600.

Rhea-AI Filing Summary

Lilly Endowment Inc. filed a Form 144 notice to sell up to 220,000 shares of Eli Lilly and Company (LLY) common stock, reflecting an aggregate market value of $197,236,600. The filing lists J.P. Morgan Securities LLC as broker and an approximate sale date of 11/04/2025.

Shares outstanding were 945,383,757. The Endowment reports prior sales in the last three months, including 351,015 shares on 10/01/2025 for $284,653,451.48 and 300,000 shares on 11/03/2025 for $266,648,940. The securities trace back to a historical gift acquisition from the J.K. Lilly Sr. Trust.

Insights

Securities counsel

Administrative notice for resale by an affiliate; neutral impact.

Lilly Endowment Inc. submitted a Form 144 indicating intent to sell up to 220,000 LLY shares with an aggregate market value of $197,236,600. The filing names J.P. Morgan Securities LLC as broker and targets an approximate sale date of 11/04/2025.

Form 144 is a notice requirement under Rule 144 for affiliates. The excerpt also lists recent sale activity with specific dates and gross proceeds. These details document compliance steps and historical sales; actual market impact depends on execution and volumes relative to trading liquidity.

The filing ties the shares to a historic gift from the J.K. Lilly Sr. Trust and shows 945,383,757 shares outstanding. Subsequent filings may update actual shares sold and proceeds if transactions occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lilly Endowment file regarding Eli Lilly (LLY)?

A Form 144 notice to sell up to 220,000 shares of Eli Lilly common stock.

What is the aggregate market value of the proposed LLY sale?

The filing shows an aggregate market value of $197,236,600 for the 220,000 shares.

When is the approximate sale date for the LLY shares?

The filing lists an approximate sale date of 11/04/2025.

Which broker is handling the proposed LLY share sale?

The broker named is J.P. Morgan Securities LLC.

How many Eli Lilly shares are outstanding according to the notice?

The notice lists 945,383,757 shares outstanding.

What recent LLY share sales by Lilly Endowment are disclosed?

Examples include 351,015 shares on 10/01/2025 for $284,653,451.48 and 300,000 shares on 11/03/2025 for $266,648,940.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/04/2025 - 03:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000316011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ELI LILLY AND COMPANY
SEC File Number	001-06351
Address of Issuer	LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS INDIANA 46285
Phone	3172762000
Name of Person for Whose Account the Securities are To Be Sold	LILLY ENDOWMENT, INC.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 383 Madison Avenue, 7th Floor New York NY 10179	220000	197236600	945383757	11/04/2025	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	09/18/2025	106626	81531976.08
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	09/19/2025	23665	18058631.34
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	09/30/2025	113694	86793237.85
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/01/2025	351015	284653451.48
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/02/2025	112596	92503333.88
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/03/2025	192404	161220391.07
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/06/2025	161183	137041671.11
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/07/2025	26795	22722390.44
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/08/2025	101420	86234870.22
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/09/2025	10602	9038053.39
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/10/2025	3658	3157720.58
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/31/2025	301342	260164971.74
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	11/03/2025	300000	266648940

144: Remarks and Signature

Remarks
Date of Notice	11/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Diane M. Stenson, Vice President & Treasurer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)